檢索結果 - Arunan Kaliyaperumal
- Showing 1 - 9 results of 9
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus 由 Barbara Sullivan, Wayne Tsuji, Alan Kivitz, Joanna Peng, Gregory E. Arnold, Michael Boedigheimer, Kit Chiu, C L Green, Arunan Kaliyaperumal, C. Wang, John Ferbas, James Chung
出版 2016Artigo -
8
Development of a Human Antibody Tolerant Mouse Model to Assess the Immunogenicity Risk Due to Aggregated Biotherapeutics 由 Vivian Bi, Vibha Jawa, Marisa K. Joubert, Arunan Kaliyaperumal, Catherine M. Eakin, Karen Richmond, Oscar Pan, Jilin Sun, Martha Hokom, Theresa J. Goletz, Jette Wypych, Lei Zhou, Bruce A. Kerwin, Linda O. Narhi, Taruna Arora
出版 2013Artigo -
9
Treatment of systemic lupus erythematosus patients with the BAFF antagonist “peptibody” blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b tria... 由 William Stohl, Joan T. Merrill, R. John Looney, Jill P. Buyon, Daniel J. Wallace, Michael H. Weisman, Ellen M. Ginzler, Blaire Cooke, Donna Holloway, Arunan Kaliyaperumal, Kameswara R. Kuchimanchi, Tsui Chern Cheah, Erik Rasmussen, John Ferbas, Shelley Sims Belouski, Wayne Tsuji, Debra Zack
出版 2015Artigo
相關主題
Immunology
Medicine
Antibody
Biology
Internal medicine
Antigen
Disease
Immune system
Systemic lupus erythematosus
Autoantibody
Molecular biology
Epitope
Lupus nephritis
Receptor
T cell
Autoimmune disease
Autoimmunity
DNA
Genetics
Histone
Immunogenicity
Nucleosome
Pathology
Pharmacology
Adalimumab
Adverse effect
Alternative medicine
Antagonist
Antigen presentation
B cell